Skip to main content
Przejdź do strony domowej Komisji Europejskiej (odnośnik otworzy się w nowym oknie)
polski pl
CORDIS - Wyniki badań wspieranych przez UE
CORDIS

Event category

Zawartość zarchiwizowana w dniu 2022-07-06

Article available in the following languages:

EN

HETEROGENEITY AND EVOLUTION IN CANCER

Chairpersons and organizing committee:
Fátima Al-Shahrour, Spanish National Cancer Research Centre, CNIO, Spain
Arnold Levine, The Simons Center for Systems Biology, Institute for Advanced Study, US
Raúl Rabadán, Columbia Systems Biology, Columbia University, US
Simon Tavaré, the Irving Institute of Cancer Dynamics at Columbia University, US

23 Września 2019 - 25 Września 2019
Spain
© CNIO
Cancers are dynamical and heterogeneous biological processes. Heterogeneity and evolution are the main factors driving oncogenesis, growth, invasion and failure of therapy. Longitudinal, multi-sampling and single cell genomic and transcriptomic characterization of tumors allows to reconstruct their changes and to link them to clinically relevant phenotypes. This workshop will bring together a community of interdisciplinary researchers developing tools to study these processes and applying them to large numbers of tumors.

Słowa kluczowe

Cancer Genomics, Bioinformatics, Heterogeneity, Personalized Medicine, Tumor evolution, Systems Biology, Computational methods, Pharmacogenomics, Translational, Clonal evolution, single-cell, transcriptomics, sequencing

Moja broszura 0 0